The global deep brain stimulation market reached US$ 800.12 million in 2023 and is expected to reach US$ 1,585.24 million by 2031 growing with a CAGR of 9.1% during the forecast period 2024-2031.

Deep Brain Stimulation Devices Market analysis, according to DataM Intelligence, offers more than just an overview, it investigates the underlying aspects of the sector. The study provides an overview, the research explores the hidden aspects of the sector, breaking down its intricate dynamics, charting regional dominance, spotting demand patterns, and spotting prospective breakthroughs that could influence how businesses operate in the future.

Deep brain stimulation (DBS) devices are medical implants used to treat neurological disorders by delivering electrical impulses to specific areas of the brain. These devices consist of electrodes implanted in the brain, a pulse generator placed under the skin, and connecting wires. DBS is commonly used for conditions such as Parkinson’s disease, essential tremor, and dystonia, helping to regulate abnormal brain activity and improve motor function. The therapy is adjustable and reversible, offering a personalized approach to managing movement disorders and other neurological conditions.

Forecast Growth Projected:

List of the Key Players in the  Deep Brain Stimulation Devices Market:

Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Aleva Neurotherapeutics, NeuroPace, Inc., SceneRay Co., Ltd., PINS Medical, Renishaw plc., BrainsWay Ltd., inomed Medizintechnik GmbH.

Segment Covered in the  Deep Brain Stimulation Devices Market:

By Product Type

• Single-Channel Systems
• Dual-Channel Systems 

By Battery Type

• Rechargeable Systems
• Non-Rechargeable Systems 

By Stimulation Type

• Constant Current Devices
• Voltage-Controlled Devices

By Application

• Movement Disorders
• Psychiatric Disorders
• Epilepsy
• Chronic Pain
• Alzheimer's Disease
• Tourette Syndrome
• Others

By End-User 

• Hospitals and Clinics
• Neurological Centers
• Ambulatory Surgical Centers
• Others

Industry Development:

In April 2024, Medtronic India introduced the NeuroSmart™ Portable Micro Electrode Recording (MER) Navigation System for deep brain stimulation (DBS) in Parkinson’s disease treatment. Developed by Alpha Omega Engineering, this system features advanced neurophysiological mapping to enable precise electrode placement while recording neural activity. With HaGuide automatic navigation, it enhances target localization, ensuring optimal symptom relief for patients.

Regional Break out:

The global Deep Brain Stimulation Devices Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of MicroRNA manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of MicroRNA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Deep Brain Stimulation Devices Market?

➠ Who are the global key manufacturers of the MicroRNA Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Deep Brain Stimulation Devices Market opportunities and threats faced by the vendors in the global MicroRNA Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Deep Brain Stimulation Devices Market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.